These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16117313)

  • 1. Cost-efficiency of nonsteroidal anti-inflammatory drug prescribing in Zagreb, Croatia.
    Vukusić I; Stimac D; Culig J
    Coll Antropol; 2005 Jun; 29(1):143-7. PubMed ID: 16117313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm).
    Vlahovic-Palcevski V; Wettermark B; Bergman U
    Eur J Clin Pharmacol; 2002 Jun; 58(3):209-14. PubMed ID: 12107607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drug usage and gastrointestinal outcomes in the Republic of Serbia.
    Petric M; Tasic L; Sukljevic S
    J Pain Palliat Care Pharmacother; 2009; 23(1):40-7. PubMed ID: 19296354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-conscious prescribing of nonsteroidal anti-inflammatory drugs for adults with arthritis. A review and suggestions.
    Greene JM; Winickoff RN
    Arch Intern Med; 1992 Oct; 152(10):1995-2002. PubMed ID: 1417372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee.
    McManus P; Primrose JG; Henry DA; Birkett DJ; Lindner J; Day RO
    Med J Aust; 1996 May; 164(10):589-92. PubMed ID: 8637461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outpatient utilization of non-steroidal anti-inflammatory drugs in South Bačka District, Serbia.
    Calasan J; Mijatović V; Horvat O; Varga J; Sabo A; Stilinović N
    Int J Clin Pharm; 2011 Apr; 33(2):246-51. PubMed ID: 21744192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing outpatient costs of nonsteroidal antiinflammatory drugs at a Department of Veterans Affairs teaching hospital.
    Drexler PG; Lambdin CS
    J Pharm Technol; 1993; 9(1):10-3. PubMed ID: 10123760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in Switzerland.
    Delcò F; Michetti P; Beglinger C; Fried M; Szucs TD
    Digestion; 2004; 69(1):10-9. PubMed ID: 14755148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness and frequency of potential side effects on nonsteroidal anti-inflammatory drugs among the Jordanian patient population.
    Albsoul-Younes AM; Jabateh SK; Abdel-Hafiz SM; Al-Safi SA
    Saudi Med J; 2004 Jul; 25(7):907-11. PubMed ID: 15235698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost stratification of nonsteroidal anti-inflammatory drug-associated gastrointestinal side effects].
    Lanas A
    Med Clin (Barc); 2000; 114 Suppl 3():46-53. PubMed ID: 10994564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic consequences of NSAID-induced gastrointestinal damage.
    de Pouvourville G; Tasch RF
    Eur J Rheumatol Inflamm; 1993; 13(1):33-40. PubMed ID: 7821337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis.
    Inotai A; Mészáros A
    Int J Technol Assess Health Care; 2009 Apr; 25(2):190-5. PubMed ID: 19366498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
    Hur C; Chan AT; Tramontano AC; Gazelle GS
    Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
    Biskupiak JE; Brixner DI; Howard K; Oderda GM
    J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing.
    Barozzi N; Tett SE
    Clin Ther; 2009 Apr; 31(4):849-61. PubMed ID: 19446158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost savings using a stepped-care prescribing protocol for nonsteroidal anti-inflammatory drugs.
    Jones DL; Kroenke K; Landry FJ; Tomich DJ; Ferrel RJ
    JAMA; 1996 Mar; 275(12):926-30. PubMed ID: 8598620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
    Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA
    Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
    Chan FK; Abraham NS; Scheiman JM; Laine L;
    Am J Gastroenterol; 2008 Nov; 103(11):2908-18. PubMed ID: 18853980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
    van Staa TP; Rietbrock S; Setakis E; Leufkens HG
    J Intern Med; 2008 Nov; 264(5):481-92. PubMed ID: 18624902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal.
    Davies NM; Reynolds JK; Undeberg MR; Gates BJ; Ohgami Y; Vega-Villa KR
    Expert Rev Neurother; 2006 Nov; 6(11):1643-55. PubMed ID: 17144779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.